An upgraded compensation package will see the owners of Purdue Pharma pay around $6 billion to bring an end to civil litigation related to the opioid epidemic i 4 March 2022
The High Court in London has ruled against attempts by Servier to limit damages it owes for infringements of competition law in the sale and supply of a widely- 22 February 2022
There are fears that US biotech company Moderna could undermine the World Health Organization’s (WHO) efforts to manufacture more mRNA vaccines in Africa, after 14 February 2022
In Latin America as with across the globe, the pharmaceutical sector works to consolidate a solid scheme of protection of intellectual property (IP), incentiviz 21 January 2022
So-called ‘pharma bro’ Martin Shkreli has been held liable for antitrust claims brought by the US Federal Trade Commission (FTC) and a group of seven state enfo 18 January 2022
Adrian Tombling, partner and life sciences sector specialist at European intellectual property firm, Withers & Rogers, offers an Expert View on why patents are 4 January 2022
US biotech Moderna has taken a more conciliatory approach in a row with the National Institutes of Health (NIH) over who is responsible for the creation of the 20 December 2021
Swiss anti-counterfeit medicine group Fight the Fakes Alliance (FTF Alliance) is gearing up for a week of action to help raise awareness around the issue of fak 25 November 2021
A commercial stage biopharmaceutical R&D company, focused on the development of products that address the medical challenges in the therapeutic area of anti-infectives.